Abacus Life Earnings Call Highlights Growth Momentum

Abacus Life, Inc. ((ABX)) has held its Q1 earnings call. Read on for the main highlights of the call.

Abacus Life, Inc. delivered a largely upbeat earnings call, highlighting strong revenue growth, expanding profitability and a sharp turnaround in cash generation. Management acknowledged higher expenses, modest margin pressure and execution risks around securitization and new products, but emphasized that fundraising momentum and portfolio performance are positioning the company for scaled growth.

Raised Guidance Signals Confidence in Earnings Power

Abacus raised its full-year 2026 adjusted net income outlook to a range of $100 million to $106 million, implying adjusted earnings per share of $1.00 to $1.05. For the second quarter, the company guided to adjusted net income of $24 million to $26 million, or $0.24 to $0.26 per share, underscoring management’s confidence after a solid start to the year.

Revenue Jumps on Life Solutions and Fee Growth

Total revenue climbed 34.6% year over year to $59.4 million in the first quarter, up from $44.1 million a year earlier. The advance was driven primarily by $50.6 million from Life Solutions and $8.5 million of asset management fees, reflecting expanding scale across both sides of the business.

Profitability Expands on Both Adjusted and GAAP Bases

Adjusted net income increased 16.6% to $20.1 million compared with $17.3 million in the prior-year quarter, supported by operating leverage in the model. Adjusted EBITDA surged 33.3% to $32.7 million with a robust 55% margin, while GAAP net income attributable to Abacus rose 59% to $7.3 million, or $0.07 per diluted share.

Operating Cash Flow Swings Sharply Positive

The company generated $91.7 million of operating cash flow in the first quarter, a dramatic improvement from negative $61.6 million in the year-ago period. Management attributed the more than $153 million swing to policy cash flows, the wind-up of a key fund and greater operating efficiency as scale increases.

Fundraising and Deal Pipeline Gain Momentum

Abacus raised $288 million into its longevity funds during the quarter, following $275 million in the previous quarter, highlighting strong investor appetite. The firm reviewed roughly 9,000 qualified policies in the period, nearly matching the entire volume reviewed in 2025, and noted that new fund vintages have attracted nearly $1 billion since inception.

Portfolio Metrics Exceed Return Targets

Average realized gains reached 26% in the quarter, well above the company’s 20% target and underscoring strong asset performance. The portfolio showed an annualized turnover of 1.9 times within the 1.5 to 2 times target, with seasoned assets carrying a weighted average life expectancy of 46 months and insured age of 88 years, indicating disciplined underwriting.

LMA Income II Exit Underscores Investor Confidence

The LMA Income II fund, with roughly $115 million in assets under management, completed its initial term and returned capital to investors fully on schedule. Approximately one-third of investors chose to extend and another third reinvested, signaling confidence in Abacus’s strategy while also reducing consolidated reporting complexity for the company.

Balance Sheet Shows Improved Flexibility

The firm ended the quarter with $37.2 million in cash and $392.8 million in policy assets on its balance sheet, providing a substantial asset base for future monetization. Reported long-term debt declined to about $330 million due to fund-related deconsolidation, while adjusted return on equity reached 19% and adjusted return on invested capital hit 17%, with recourse leverage around two times EBITDA and capacity to increase if needed.

Strategic Initiatives Target New Distribution and Funding

Management highlighted progress on a distribution alliance with Manning & Napier, expecting early benefits to emerge in the second quarter as new channels open for longevity products. Abacus is also planning a second securitization in late second quarter or early third quarter, aiming to recycle capital and diversify its funding sources to support continued growth.

Higher Operating Expenses Reflect Growth Investments

Total operating expenses rose to approximately $34.8 million from $19.6 million a year earlier, excluding certain fair value effects, marking a notable cost increase. The company characterized the higher sales and marketing, general and administrative, acquisition and special project spending as intentional investments to support scale and strategic initiatives.

Margins See Slight Compression Amid Expansion

Despite strong EBITDA growth, the adjusted EBITDA margin edged down to 55% from 56% in the prior-year period, reflecting modest compression. Management suggested this outcome is acceptable given the growth-oriented spending underway and the margin level remains high by industry standards.

Leverage and Liquidity Require Ongoing Discipline

While reported long-term debt fell to about $330 million, Abacus emphasized that the $76.7 million reduction was mainly an accounting effect from fund deconsolidation rather than true deleveraging. With cash on hand at $37.2 million, the company stressed the importance of ongoing monetization and careful financing management as deployment, fundraising and securitization activities scale.

Execution Risks Around Securitization and New Products

Management acknowledged that the planned second securitization could slip from late second quarter into the third quarter, introducing timing risk to capital recycling plans. The review process for a new interval fund also remains ongoing, with no firm regulatory timeline, which could delay certain anticipated asset and funding inflows.

AUM and Deployment Patterns Remain Variable

Assets under management were relatively flat compared with the prior quarter, a point addressed in the question-and-answer session as investors probed growth pacing. Capital deployment reached $163.6 million in the quarter versus prior quarterly levels such as $230 million, and management suggested using a modeling range of $130 million to $150 million while noting that quarterly activity will naturally fluctuate.

Competitive Market Pressures Purchase Discounts

Increased competition among buyers has led to lower purchase discount rates, meaning Abacus pays more upfront for policies but can benefit from higher asset values. Management framed the trend as broadly positive given elevated sale prices, while cautioning that persistent discount compression could pressure spreads over time and will need close monitoring.

Guidance Points to Continued Growth and Scale Ambitions

Forward guidance reflects confidence in the trajectory of earnings and scale, with raised adjusted net income and earnings per share ranges for 2026 after a strong first quarter. Management also reiterated longer-term aspirations of growing assets under management to $30 billion and adjusted EBITDA to $250 million by 2028, underpinned by fundraising, securitizations and expanded distribution partnerships.

Abacus Life’s latest earnings call painted a picture of a company balancing aggressive growth with disciplined risk management as it scales its longevity platform. Robust revenue gains, higher profitability and strong portfolio metrics outweighed concerns over rising expenses, modest margin compression and timing risks, leaving investors with a constructive view of the company’s medium-term prospects.